Myanmar vs Viet Nam: HIV/AIDS deaths averted by antiretroviral therapy
Myanmar
8,848 deaths
in 2024
Viet Nam
8,037 deaths
in 2024
Myanmar rank
26th
Viet Nam rank
28th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Myanmar
- Viet Nam
How they compare
Myanmar currently reports 8,848 deaths against 8,037 deaths in Viet Nam, a difference of 811 deaths.
That makes Myanmar's figure about 1.1 times Viet Nam's.
The two have swapped places 1 time across 35 shared years of data; in 1990 it was Viet Nam ahead.
Myanmar ranks 26th and Viet Nam ranks 28th of 157 countries.
Across the 4 decades both report, Myanmar averaged higher in 1 and Viet Nam in 2.
Head to head by decade
| Decade | Myanmar | Viet Nam | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 792.59 deaths | 1,430 deaths | 637.06 deaths | Viet Nam |
| 2010s | 7,079 deaths | 8,644 deaths | 1,564 deaths | Viet Nam |
| 2020s | 9,387 deaths | 8,576 deaths | 811.26 deaths | Myanmar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Myanmar or Viet Nam?
- Myanmar, at 8,848 deaths against 8,037 deaths in Viet Nam as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Myanmar and Viet Nam?
- 811 deaths, with Myanmar ahead.
- How many years of comparable data are there for Myanmar and Viet Nam?
- 35 years are reported by both, from 1990 to 2024.
- How do Myanmar and Viet Nam rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Myanmar ranks 26th and Viet Nam ranks 28th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.